391 related articles for article (PubMed ID: 27578074)
21. What are new treatment concepts in systemic itch?
Kremer AE
Exp Dermatol; 2019 Dec; 28(12):1485-1492. PubMed ID: 31452276
[TBL] [Abstract][Full Text] [Related]
22. Effective control of recalcitrant pruritus by bevacizumab: a possible role for vascular endothelial growth factor in chronic itch?
Krause K; Krull C; Kessler B; Lange-Asschenfeldt B; Maurer M; Metz M
Acta Derm Venereol; 2013 Mar; 93(2):175-9. PubMed ID: 22930318
[TBL] [Abstract][Full Text] [Related]
23. [Pruritus in systemic diseases : Common and rare etiologies].
Kremer AE; Mettang T
Hautarzt; 2016 Aug; 67(8):606-14. PubMed ID: 27376752
[TBL] [Abstract][Full Text] [Related]
24. Emerging Treatments and Novel Pathways in Pruritus.
Besner Morin C; Misery L
J Cutan Med Surg; 2019; 23(5):528-536. PubMed ID: 31167547
[TBL] [Abstract][Full Text] [Related]
25. Trial of Nemolizumab in Moderate-to-Severe Prurigo Nodularis.
Ständer S; Yosipovitch G; Legat FJ; Lacour JP; Paul C; Narbutt J; Bieber T; Misery L; Wollenberg A; Reich A; Ahmad F; Piketty C
N Engl J Med; 2020 Feb; 382(8):706-716. PubMed ID: 32074418
[TBL] [Abstract][Full Text] [Related]
26. Pharmacological Characterization of a Novel Mouse Model of Cholestatic Pruritus.
Andoh T; Suzuki K; Konno M; Tsuneyama K; Kuraishi Y
Biol Pharm Bull; 2020; 43(7):1111-1117. PubMed ID: 32612073
[TBL] [Abstract][Full Text] [Related]
27. Serlopitant reduced pruritus in patients with prurigo nodularis in a phase 2, randomized, placebo-controlled trial.
Ständer S; Kwon P; Hirman J; Perlman AJ; Weisshaar E; Metz M; Luger TA;
J Am Acad Dermatol; 2019 May; 80(5):1395-1402. PubMed ID: 30894279
[TBL] [Abstract][Full Text] [Related]
28. Nalfurafine hydrochloride: a new drug for the treatment of uremic pruritus in hemodialysis patients.
Nakao K; Mochizuki H
Drugs Today (Barc); 2009 May; 45(5):323-9. PubMed ID: 19584962
[TBL] [Abstract][Full Text] [Related]
29. Itch: scratching more than the surface.
Twycross R; Greaves MW; Handwerker H; Jones EA; Libretto SE; Szepietowski JC; Zylicz Z
QJM; 2003 Jan; 96(1):7-26. PubMed ID: 12509645
[TBL] [Abstract][Full Text] [Related]
30. Pruritus in cutaneous T-cell lymphomas: frequent, often severe and difficult to treat.
Meyer N; Paul C; Misery L
Acta Derm Venereol; 2010; 90(1):12-7. PubMed ID: 20107719
[TBL] [Abstract][Full Text] [Related]
31. A review of pruritus.
Denman ST
J Am Acad Dermatol; 1986 Mar; 14(3):375-92. PubMed ID: 3514695
[TBL] [Abstract][Full Text] [Related]
32. The NK1 receptor antagonist serlopitant for treatment of chronic pruritus.
Ständer S; Spellman MC; Kwon P; Yosipovitch G
Expert Opin Investig Drugs; 2019 Aug; 28(8):659-666. PubMed ID: 31272246
[No Abstract] [Full Text] [Related]
33. [Role of aprepitant in the management of pruritus in a patient with cutaneous T-cell lymphoma].
Palacios Zabalza I; López de Torre Querejazu A; Santos Ibañez A
Farm Hosp; 2014 Apr; 38(2):145-7. PubMed ID: 24669900
[TBL] [Abstract][Full Text] [Related]
34. Treatment of pruritus in early-stage hypopigmented mycosis fungoides with aprepitant.
Jiménez Gallo D; Albarrán Planelles C; Linares Barrios M; Fernández Anguita MJ; Márquez Enríquez J; Rodríguez Mateos ME
Dermatol Ther; 2014; 27(3):178-82. PubMed ID: 24517320
[TBL] [Abstract][Full Text] [Related]
35. A New Generation of Treatments for Itch.
Fowler E; Yosipovitch G
Acta Derm Venereol; 2020 Jan; 100(2):adv00027. PubMed ID: 31940047
[TBL] [Abstract][Full Text] [Related]
36. Advances in therapeutic strategies for the treatment of pruritus.
Stull C; Lavery MJ; Yosipovitch G
Expert Opin Pharmacother; 2016; 17(5):671-87. PubMed ID: 26630350
[TBL] [Abstract][Full Text] [Related]
37. Kappa-opioid system in uremic pruritus: multicenter, randomized, double-blind, placebo-controlled clinical studies.
Wikström B; Gellert R; Ladefoged SD; Danda Y; Akai M; Ide K; Ogasawara M; Kawashima Y; Ueno K; Mori A; Ueno Y
J Am Soc Nephrol; 2005 Dec; 16(12):3742-7. PubMed ID: 16251241
[TBL] [Abstract][Full Text] [Related]
38. Medical treatment of pruritus.
Ständer S; Weisshaar E
Expert Opin Emerg Drugs; 2012 Sep; 17(3):335-45. PubMed ID: 22870909
[TBL] [Abstract][Full Text] [Related]
39. Treatment of cholestatic pruritus in children.
Cies JJ; Giamalis JN
Am J Health Syst Pharm; 2007 Jun; 64(11):1157-62. PubMed ID: 17519457
[TBL] [Abstract][Full Text] [Related]
40. Chronic Pruritus: Current and Emerging Treatment Options.
Pereira MP; Ständer S
Drugs; 2017 Jun; 77(9):999-1007. PubMed ID: 28466423
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
